INTERCEPT PHARMACEUTICALS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for INTERCEPT PHARMACEUTICALS IN NOTE 3.500% 2/1, CUSIP 45845PAC2.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for INTERCEPT PHARMACEUTICALS IN NOTE 3.500% 2/1, CUSIP 45845PAC2.